Trevi Therapeutics Inc.
TRVI | NASDAQ
$15.14
+$0.25 (+1.68%)
Sep 22, 2026, 1:45 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 34K | n/a | n/a | n/a | n/a | 38K | n/a | 38K | 35K | 35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12K | n/a | n/a | n/a |
Gross Profit | n/a | -34K | n/a | n/a | n/a | n/a | -38K | n/a | -38K | -35K | -35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12K | n/a | n/a | n/a |
Operating Income | -20.51M | -14.91M | -10.22M | -13.92M | -13.72M | -11.47M | -12.24M | -14.09M | -13.29M | -11.91M | -8.93M | -9.05M | -8.38M | -7.56M | -6.66M | -8.41M | -7.82M | -7.03M | -8.27M | -6.95M | -9.17M | -8.09M |
Interest Income | 2.7M | 1.7M | 1.9M | 2.1M | 1.41M | 1.13M | 843K | 826K | 935K | 998K | 1.14M | 1.18M | 1.21M | 1.22M | 1.12M | 424K | 195K | 4K | 3K | 2K | 2K | 3K |
Pretax Income | -17.82M | -13.21M | -8.33M | -11.82M | -12.32M | -10.35M | -11.4M | -13.27M | -12.36M | -10.91M | -7.8M | -7.71M | -7.18M | -6.41M | -5.53M | -8.27M | -8.06M | -7.33M | -8.53M | -7.25M | -9.8M | -8.39M |
Net Income | -17.8M | -13.19M | -8.32M | -11.8M | -12.3M | -10.34M | -11.42M | -13.24M | -12.35M | -10.9M | -7.82M | -7.7M | -7.15M | -6.4M | -5.51M | -8.27M | -8.05M | -7.33M | -8.52M | -7.26M | -9.79M | -8.37M |
Selling & General & Admin | 5.36M | 4.97M | 4.03M | 3.83M | 4.33M | 3.66M | 2.88M | 2.86M | 3.23M | 3.07M | 2.38M | 2.72M | 2.54M | 2.56M | 2.34M | 2.64M | 2.72M | 2.38M | 2.09M | 2.23M | 2.67M | 2.5M |
Research & Development | 15.15M | 9.94M | 6.19M | 10.09M | 9.39M | 7.81M | 9.33M | 11.22M | 10.02M | 8.8M | 6.52M | 6.32M | 5.84M | 5M | 4.32M | 5.77M | 5.1M | 4.65M | 6.18M | 4.72M | 6.5M | 5.59M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 20.51M | 14.91M | 10.22M | 13.92M | 13.72M | 11.47M | 12.21M | 14.09M | 13.25M | 11.87M | 8.9M | 9.05M | 8.38M | 7.56M | 6.66M | 8.41M | 7.82M | 7.03M | 8.27M | 6.95M | 9.17M | 8.09M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 1K | 1K | 1K | 4K | 3K | 151K | 231K | 274K | 292K | 295K | 302K | 309K | 303K | 296K | 294K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -38K | -35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 20.51M | 14.91M | 10.22M | 13.92M | 13.72M | 11.47M | 12.24M | 14.09M | 13.29M | 11.91M | 8.93M | 9.05M | 8.38M | 7.56M | 6.66M | 8.41M | 7.82M | 7.03M | 8.27M | 6.95M | 9.17M | 8.09M |
Income Tax Expense | -19K | -20K | -16K | -15K | -21K | -11K | 16K | -31K | -8K | -8K | 18K | -13K | -30K | -7K | -20K | -7K | -4K | -5K | -6K | 2K | -2K | -15K |
Shares Outstanding (Basic) | 156.6M | 145.59M | 145.5M | 145.1M | 130.35M | 117.61M | 106.01M | 101.04M | 101.04M | 99.52M | 99.49M | 99.33M | 98.7M | 98.61M | 98.13M | 68.9M | 59.54M | 30.81M | 21.61M | 21.61M | 20.12M | 19.42M |
Shares Outstanding (Diluted) | 156.6M | 145.59M | 145.5M | 145.1M | 130.35M | 117.61M | 106.01M | 101.04M | 101.04M | 99.52M | 99.49M | 99.33M | 98.7M | 98.61M | 98.13M | 68.9M | 59.54M | 30.81M | 21.61M | 21.61M | 20.12M | 19.42M |
EPS (Basic) | -0.11 | -0.09 | -0.06 | -0.08 | -0.09 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 | -0.08 | -0.08 | -0.07 | -0.06 | -0.06 | -0.12 | -0.14 | -0.24 | -0.39 | -0.34 | -0.49 | -0.43 |
EPS (Diluted) | -0.11 | -0.09 | -0.06 | -0.08 | -0.09 | -0.09 | -0.11 | -0.13 | -0.12 | -0.11 | -0.08 | -0.08 | -0.07 | -0.06 | -0.06 | -0.12 | -0.14 | -0.24 | -0.39 | -0.34 | -0.49 | -0.43 |
EBITDA | -17.82M | -13.18M | -8.3M | -11.78M | -12.28M | -10.31M | -11.36M | -13.24M | -12.32M | -10.87M | -7.76M | -7.67M | -6.99M | -6.16M | -5.24M | -7.97M | -7.75M | -7.02M | -8.21M | -6.94M | -9.49M | -8.08M |
EBIT | -17.82M | -13.21M | -8.33M | -11.82M | -12.32M | -10.35M | -11.4M | -13.27M | -12.36M | -10.91M | -7.8M | -7.71M | -7.02M | -6.18M | -5.25M | -7.98M | -7.76M | -7.03M | -8.22M | -6.95M | -9.5M | -8.09M |
Depreciation & Amortization | n/a | 34K | 31K | 38K | 38K | 37K | 38K | 36K | 38K | 35K | 35K | 35K | 34K | 19K | 15K | 9K | 8K | 11K | 12K | 13K | 12K | 13K |
Add to Watchlist
Select watchlists to add or remove TRVI